Propanol

Propanol

SCHEMBL1785779

CCCO.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Propanol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propanol SCHEMBL4269564 1.00
Propanol SCHEMBL6098189 1.00
Propanol SCHEMBL4778557 1.00
Propanol SCHEMBL27472513 1.00
Propanol SCHEMBL28853258 0.95
Propanol SCHEMBL28968828 0.95
Propanol SCHEMBL8369005 0.95 ALDH1A1 (0.50)
Propanol SCHEMBL28381868 0.95
Propanol SCHEMBL3488334 0.95
Propanol SCHEMBL17310395 0.95

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025125058-A1 METHOD FOR THE ORGANIC PREPARATION OF A CATALYST IN THE PRESENCE OF A HYDROGEN HALIDE ADDITIVE IFP Energies Nouvelles (FR) 2025-06-19 WO claimed
US-11834425-B2 Full continuous-flow preparation method of vitamin B1 FUDAN UNIVERSITY (CN) 2023-12-05 US claimed
US-20230183196-A1 FULL CONTINUOUS-FLOW PREPARATION METHOD OF VITAMIN B1 FUDAN UNIVERSITY (CN) 2023-06-15 US claimed
CN-116064165-A Agent for treating coking and blocking of hydrogenation unit and its application 中国石油化工股份有限公司 2023-05-05 CN claimed
CN-113563007-A High-strength composite fiber expansion anti-cracking agent and preparation process thereof 南京晶磊兴建材有限公司 2021-10-29 CN claimed
CN-113336467-A Low-alkali waterproof anti-cracking expanding agent 南京晶磊兴建材有限公司 2021-09-03 CN claimed
CN-107417663-B A kind of preparation method of high-purity (S) -3- methylamino -1- (thiophene -2- base) propyl alcohol 台州职业技术学院 2019-05-28 CN claimed
CN-107417663-A A kind of preparation method of high-purity (S) 3 methylamino 1 (base of thiophene 2) propyl alcohol 台州职业技术学院 2017-12-01 CN claimed
CN-106632131-A Hexythiazox and preparation method thereof 温州大学 2017-05-10 CN claimed
CN-105669699-A Preparation method of prasugrel hydrochloride 山东罗欣药业集团股份有限公司 2016-06-15 CN claimed
CN-104370851-A Synthesis method of 2-aminomethyl-thiazole hydrochloride KEJIE BIO SUZHOU PHARMACEUTICALS CO LTD 2015-02-25 CN claimed
CN-103570645-A Method for preparing N-(2,6-dimethyl phenyl)-2-(1-piperazine)acetamide SHANGHAI DESANO CHEMICAL PHARM 2014-02-12 CN claimed
CN-103420920-A Rilpivrine hydrochloride alcoholate polymorphs and preparation methods thereof SHANGHAI DESANO PHARMACEUTICAL CO LTD 2013-12-04 CN claimed
EP-0629625-B1 Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof LILLY CO ELI (US) 2002-10-09 EP claimed
CN-1053446-C Novel thiomarinol derivatives, and processes for their preparation SANKYO CO (JP) 2000-06-14 CN claimed
US-5578720-A ETHANOL, METHANOL AND PROPANOL SOLVATES; ANTIBIOTICS ELI LILLY AND COMPANY (US) 1996-11-26 US claimed
EP-0629625-A1 Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof ELI LILLY AND COMPANY (US) 1994-12-21 EP claimed
CN-1092811-A New thiomarinol derivative and preparation method thereof SANKYO CO (JP) 1994-09-28 CN claimed
US-12398140-B2 Substituted pyrrolo [2,3-d]pyrimidines for treating familial dysautonomia PTC THERAPEUTICS, INC. (US) 2025-08-26 US disclosed
US-3937832-A ADMINISTERING SOCIETE ANONYME DITE: HEXACHIMIE (FR) 1976-02-10 US disclosed